Bowen Fu Selected Research

carvacrol

6/2018

The transient receptor potential vanilloid-3 regulates hypoxia-mediated pulmonary artery smooth muscle cells proliferation via PI3K/AKT signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bowen Fu Research Topics

Disease

4	Neoplasms (Cancer) 10/2022 - 01/2018
3	Cardiomegaly (Heart Hypertrophy) 03/2020 - 12/2018
2	Osteoporosis 01/2021 - 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Colitis 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Melanoma (Melanoma, Malignant) 10/2022
1	Hyperthermia 10/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2021
1	Acute Coronary Syndrome 12/2021
1	Coronary Disease (Coronary Heart Disease) 12/2021
1	Chronic Renal Insufficiency 08/2020
1	Obesity 08/2020
1	Heart Failure 08/2020
1	Diarrhea 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Hypoxia (Hypoxemia) 06/2018
1	Pulmonary Arterial Hypertension 06/2018

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2018
1	Thalidomide (Thalomid)FDA Link 01/2023
1	CytokinesIBA 01/2023
1	polydopamineIBA 01/2023
1	VaccinesIBA 10/2022
1	Imiquimod (Aldara)FDA LinkGeneric 10/2022
1	Fibrinogen (Factor I)FDA Link 12/2021
1	AlbuminsIBA 12/2021
1	Ubiquitin-Specific ProteasesIBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	Lipocalin-2IBA 08/2020
1	Biomarkers (Surrogate Marker)IBA 08/2020
1	Angiotensin IIIBA 03/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	huanglian-jie-du decoctionIBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	allicinIBA 12/2018
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 12/2018
1	Hematoxylin (Haematoxylon)IBA 06/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 06/2018
1	Ruthenium RedIBA 06/2018
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 06/2018
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2018
1	Cyclin AIBA 06/2018
1	Cyclin EIBA 06/2018
1	carvacrolIBA 06/2018
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 06/2018
1	Cyclin DIBA 06/2018

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2023 - 01/2018
2	Therapeutics 01/2023 - 10/2021
1	Immunomodulation 10/2022
1	Aftercare (After-Treatment) 10/2022
1	Immunotherapy 10/2022
1	Neoadjuvant Therapy 01/2020